PC
AGN

PointState Capital’s Allergan plc AGN Stock Holding History

PointState Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,000
Closed -$1.67M – 202
2018
Q2 		$1.67M Sell
10,000
-15,000
-60% -$2.41M 0.02% 143
2018
Q1 		$4.21M Sell
25,000
-125,000
-83% -$21M 0.05% 118
2017
Q4 		$24.5M Sell
150,000
-29,600
-16% -$5.31M 0.24% 70
2017
Q3 		$36.8M Buy
179,600
+129,600
+259% +$30.1M 0.31% 71
2017
Q2 		$12.2M Buy
50,000
+10,000
+25% +$2.35M 0.13% 80
2017
Q1 		$9.56M Buy
+40,000
New +$9.31M 0.1% 101

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PointState Capital's AGN Position: Q3 2016 in Review

PointState Capital sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 707,456 shares — an estimated $163M sold.

PointState Capital first reported a position in AGN in Q4 2013 and held it in 7 quarters. The position peaked at $430M in Q1 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • PointState Capital reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • PointState Capital sold 707,456 Allergan plc shares in Q3 2016, an estimated $163M.
  • PointState Capital first reported a position in Allergan plc in Q4 2013 and held it in 7 quarters.
  • PointState Capital's Allergan plc position peaked at $430M in Q1 2016.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on PointState Capital's 13F filing for Q3 2016, filed 14 Nov 2016.